Mounjaro could reduce heart attack risks for diabetes patients, study says

Study finds Mounjaro reduces heart attack risk by 33% in type 2 diabetes patients with heart disease

New research indicates that Mounjaro (tirzepatide) significantly lowers the risk of heart attacks in type 2 diabetes patients who also have heart disease, with a 33% reduction observed in those receiving the medication.